Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, I.-M.
Right arrow Articles by Vogelstein, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shih, I.-M.
Right arrow Articles by Vogelstein, B.
[Cancer Research 61, 818-822, February 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Evidence That Genetic Instability Occurs at an Early Stage of Colorectal Tumorigenesis1

Ie-Ming Shih, Wei Zhou, Steven N. Goodman, Christoph Lengauer, Kenneth W. Kinzler and Bert Vogelstein2

Howard Hughes Medical Institute [B. V.], Johns Hopkins Oncology Center [I-M. S., W. Z., S. N. G., C. L., K. W. K., B. V.], and Department of Pathology [I-M. S.], Johns Hopkins Medical Institutions, Baltimore, Maryland 21231


    ABSTRACT
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Chromosomal instability is believed to be a common feature of most human tumors, but the stage at which such instability originates has not been defined. At the molecular level, chromosomal instability is characterized by allelic imbalance (AI), representing losses or gains of defined chromosomal regions. We have assessed AI in early colorectal tumors using newly developed methods for assessing AI in complex cell populations. A total of 32 adenomas of average size (2 mm; range, 1–3 mm) were studied. AI of chromosome 5q markers occurred in 55% of tumors analyzed, consistent with a gatekeeping role of the adenomatous polyposis coli tumor suppressor gene located at chromosomal position 5q21. AI was also detected in each of the other four chromosomes tested. The fractions of adenomas with AI of chromosomes 1p, 8p, 15q, and 18q were 10, 19, 28, and 28%, respectively. Over 90% of the tumors exhibited AI of at least one chromosome, and 67% had allelic imbalance of a chromosome other than 5q. These findings demonstrate that AI is a common event, even in very small tumors, and suggest that chromosomal instability occurs very early during colorectal neoplasia.


    Introduction
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
It is now widely accepted that tumors result from the sequential accumulation of genetic alterations (1) . It has also been long recognized that genetic instability may be required to accumulate the large number of genetic alterations that occur during the tumorigenic process (2 , 3) . It has been proposed recently that two forms of such instability occur in CRCs.3 In ~13% of CRCs, mismatch repair deficiency leads to MIN, characterized by widespread insertions and deletions in microsatellite repeats and associated with numerous nucleotide substitutions (4 , 5) . In the remaining 87% of CRCs, CIN appears to result in a large number of gross chromosomal changes. Although the biochemical mechanisms underlying MIN are well known, the mechanisms underlying CIN are only beginning to emerge (3 , 6) .

If genetic instability is essential to human neoplasia, one might expect it to begin early during the tumorigenic process and thereby accelerate the acquisition of growth-promoting mutations. Evidence has been presented that MIN often occurs very early, prior to the occurrence of the APC gene mutations that initiate the abnormal growth phase (7) . On the other hand, the timing of CIN is uncertain. Although most CRCs are aneuploid (suggesting CIN), the prevalence of aneuploidy in benign colorectal tumors is less than in cancers and appears to increase as the tumors enlarge in size (8, 9, 10, 11, 12) . Virtually all adenomas that have been studied through karyotypic or flow cytometric methods have been rather large, containing billions of cells, and there have been few karyotypic or molecular studies focused on very small benign tumors. The choice of tumors studied previously has been dictated by the fact that small benign tumors have relatively few neoplastic cells and a higher fraction of stromal cells, presenting significant experimental obstacles.

To address the question posed above, we have studied a series of colorectal adenomas averaging 2 mm in diameter. AI, reflecting gains or losses of particular chromosomal regions, was used as a marker for CIN. To overcome the obstacles associated with the molecular genetic analysis of these small tumors, we used a recently developed PCR-based approach called digital SNP analysis, in which the alleles within a tumor sample are individually counted, one by one (13 , 14) . Using this method, we found a remarkably high degree of AI in small tumors, strongly suggesting that CIN occurs early during colorectal tumorigenesis.


    Materials and Methods
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Tissues and Tumor DNA Samples.
Formalin-fixed, paraffin-embedded tissue samples of 32 small adenomas from 27 patients and their associated normal mucosae were retrieved from the surgical pathology files of The Johns Hopkins Hospital. All of the adenomas were from sporadic cases and were obtained either from colonoscopy biopsies or harvested from colorectal resection specimens. Histologically, all adenomas demonstrated low-grade dysplasia without any evidence of high-grade dysplasia or carcinoma. The sizes of the adenomas ranged from 1 to 3 mm, with an average of 2 mm. The adenomatous areas and normal epithelium were microdissected under an inverted microscope and DNA purified using a QiaQuick PCR purification kit (Qiagen, Valencia, CA).

Digital PCR Analysis.
SNP markers on chromosomes 1p, 8p, 15q, and 18q were retrieved from the Whitehead human SNP database4 and National Cancer Institute SNP map.5 The SNP markers within the APC gene on chromosome 5q were based on common polymorphisms reported previously (15) . Forward and reverse primers were designed for each SNP, allowing the amplification of ~100-bp PCR products (Table 1)Citation . Molecular Beacons (16 , 17) were designed for each of these 24 polymorphisms. For each case, DNA from normal mucosa was first tested for heterozygosity for SNP markers on all five chromosomes. For each chromosome, one SNP that exhibited heterozygosity in the normal sample was then used to assess AI in DNA from the corresponding tumor.


View this table:
[in this window]
[in a new window]

 
Table 1 Primers and probes used for digital SNP analysis

 
Digital SNP was performed as described (13 , 14) . In brief, DNA samples were diluted and distributed to the wells of a 384-well plate at less than 1 genomic equivalent/well. PCR was performed with a touch-down protocol for all SNPs: 94°C (1 min); 4 cycles of 94°C (15 s), 64°C (15 s), 70°C (15 s); 4 cycles of 94°C (15 s), 61°C (15 s), 70°C (15 s); 4 cycles of 94°C (15 s), 58°C (15 s), 70°C (15 s); and 45 cycles of 94°C for (15 s), 55°C (15 s), 70°C (15 s). After PCR, a pair of Molecular Beacons synthesized by Gene Link (Thornwood, NY) was added to the final PCR product, along with an internal primer that allowed the generation of single-stranded DNA complementary to the Molecular Beacon. Molecular Beacons are single-stranded oligonucleotides containing a fluorescent dye and a quencher on their 5' and 3' ends, respectively. Molecular Beacons include a hairpin structure that brings the fluorphore closer to the quencher. However, if a target complementary to the loop of the beacon is present in the PCR, the stem is forced apart and the quenching is relieved (15 , 16) . For the asymmetric PCR step, the following conditions were used: 15 cycles of 94°C (15 s), 55°C (15 s), 70°C (15 s); and 1 cycle of 94°C (1 min), 60°C (5 min). The fluorescence intensity in each well was then measured in a Galaxy FLUOstar fluorometer (BMG Lab Technologies, Durham, NC), and the number of the specific alleles in each sample was determined directly from the fluorescence measurements. The PCR was set up so that one-third to two-thirds of the wells contained a template, ensuring that most signals would originate from a single-template molecule. A SPRT was used to determine whether a specific adenoma showed AI (14 , 18) .


    Results
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
Principles of Allele Counting and SPRT Analysis.
The analysis of AI in small tumors is fraught with technical difficulties. Such tumors typically contain a high fraction of nonneoplastic cells, including stromal and inflammatory components (Fig. 1)Citation . Microdissection is therefore mandatory to derive a population that is enriched in the neoplastic cell component. But analysis of the microdissected samples with genetic markers is associated with its own set of problems. To overcome such problems, we have used a technique called digital SNP, in which alleles are directly counted, one by one (14) . Because SNPs rather than microsatellite markers are used with this method, DNA degradation of the larger microsatellite alleles does not pose a problem (19) . However, because only limited amounts of DNA are purified from microdissected lesions, sampling errors can produce artifactual enrichments for one allele when conventional AI assays are used, even with SNPs. For example, if only a few template molecules are successfully amplified in the PCR, one allele may be overrepresented by chance alone. Digital SNP minimizes such sampling errors, because the exact number of alleles evaluated in each assay is determined. Rigorous statistical methods are then used to conclude whether AI is present.



View larger version (106K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 1. A, H&E-stained section of a typical adenomatous polyp used in this study. The adenoma was 2 mm in greatest dimension. B, higher magnification demonstrates dysplastic epithelium overlying the lamina propria, with abundant lymphocytes and stromal cells that are typically observed in these lesions.

 
An example of the results obtained with this approach is presented in Fig. 2Citation . DNA from normal and microdissected tumor samples was diluted in a 384-well PCR plate so that there was <1 DNA template/well. PCR was performed using a SNP for which the patient was heterozygous. The resultant PCR products were analyzed using Molecular Beacon probes to determine allelic representation. In the DNA sample from normal colonic mucosae of the patient depicted in Fig. 2Citation A, there were 29 "A" alleles (red; detected with a Hex-labeled Molecular Beacon) and 34 "G" alleles (green; detected with a fluorescein-labeled Molecular Beacon). In the sample from the small adenoma of this patient, there were 33 "A" alleles and 11 "G" alleles (Fig. 2A)Citation .



View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 2. A, examples of digital SNP genotyping data. DNA from microdissected normal (upper panel) and adenoma (bottom panel) samples was distributed to a 384-well PCR plate. After PCR, a pair of allele-specific Molecular Beacons, labeled with fluorescein or Hex, was added to each well to determine allelic status. The fluorescein: Hex fluorescence ratio was then determined. Wells that were green or red corresponded to those containing PCR products derived from only one of the two alleles. Wells with only background fluorescence were uncolored and represent wells that contained no DNA template molecules. Wells that were yellow contained an intermediate green: red fluorescence ratio, resulting from the presence of both alleles. Such results are expected based on a Poisson distribution.4 B, SPRT analysis of normal and adenoma samples from A. X axis, total number of alleles counted; Y axis, observed proportion of the two alleles. The allelic proportion of DNA from the normal colonic mucosae is below curve 2 and is therefore interpreted as being in allelic balance. In contrast, the allelic proportion in the DNA from the adenoma is above curve 1, and this tumor is interpreted to have AI.

 
To determine whether there was substantial statistical evidence for AI, we used the SPRT (19) . This method allows two probabilistic hypotheses to be compared as data accumulate and facilitates decisions about the presence or absence of AI after study of a minimum number of samples. Hypothesis 1 is that the sample is in AI, i.e., that the alleles have the expected normal allelic proportion of 50%. Hypothesis 2 is that the same one of the two alleles was absent in every tumor cell (14) . However, this does not correspond to an allelic proportion of 100% in the tumor samples because isolation of pure tumor cell populations from small adenomatous polyps is not feasible with the microdissection methods we used (Fig. 1)Citation . For example, if only 50% of the DNA from the microdissected samples originated from neoplastic cells and the other 50% originated from nonneoplastic cells, the observed allelic proportion would be 66.7%, not 100%. SPRT curves were therefore constructed to choose between the hypotheses P = 50% and P = 66.7%, using the conservative assumption that at least 50% of the DNA in the sample was derived from neoplastic cells. The two curves representing these two assumptions are depicted in Fig. 2BCitation . The number of alleles studied in each sample is plotted on the abscissa, and the observed ratio of the two alleles is plotted on the ordinate. The ratio is defined as the number of wells containing the allele that appeared to be in excess to the total number of wells containing either allele. Samples represented by points above curve 1 were interpreted to have AI. It is important to note that the confidence interval of each point above curve 1 excludes allelic proportion values that are expected to occur in normal cells (14 , 18) . Points below the bottom curve were categorized as being in allelic balance. In the example shown in Fig. 2Citation B, the allelic proportion of DNA from the normal colonic mucosae was below curve 2 and was therefore interpreted as being in allelic balance. In contrast, the allelic proportion in the DNA from the adenoma was above curve 1, and this tumor was interpreted to have AI.

AI in Small Adenomas.
We selected 32 adenomas with an average diameter of 2 mm (range, 1–3 mm) for this study (Fig. 1)Citation . Neoplastic cells from these adenomas were carefully microdissected with the contamination from nonneoplastic cells estimated at 30–60% by histological examination. DNA was purified from the microdissected tissue and used as template for digital SNP analysis. Five different chromosomal arms were evaluated for AI. For each chromosomal arm, we developed Molecular Beacon pairs that reliably distinguished paternal from maternal alleles. The sequences of the relevant primers and Molecular Beacons for the 24 different SNPs studied are detailed in Table 1Citation . Using these 24 markers, we were able to find at least one heterozygous SNP for each chromosomal arm in the great majority of patients studied.

All of the normal mucosa samples analyzed were found to be in allelic balance, because their allelic proportions were below curve 2 (data not shown). Scatterplots of the data from the tumors are shown in Fig. 3Citation and summarized in Fig. 4Citation . Among the informative cases, the percentages of samples exhibiting AI of chromosomes 1p, 5q, 8p, 15q, and 18q were 10, 55, 19, 28, and 28%, respectively. There was no significant correlation between AI and the site of adenomas or the age and sex of patients. Over 90% of the adenomas exhibited AI of at least one chromosomal arm. When chromosome 5q was excluded from analysis, 66% of the adenomas exhibited AI of at least one of the other chromosomal arms. There was no obvious clustering of the AI in the tumors (Fig. 4)Citation .



View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 3. SPRT analysis on different chromosomal arms. X axis, total number of alleles counted; Y axis, observed proportion of the two alleles for each of the chromosome arms indicated. The boundary SPRT values corresponding to a likelihood ratio of 8 are shown as curved lines, as in Fig. 2Citation . All points above the upper boundary were interpreted to have AI, whereas those below the lower boundary were interpreted to have no AI.

 


View larger version (57K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 4. Summary of digital SNP results. {blacksquare}, chromosome arms in which AI was identified through digital SNP; , chromosome arms in which both alleles were in balance; {square}, chromosome arms that could not be evaluated because all SNP markers tested were uninformative in the normal mucosae or because the allelic ratio in SPRT analysis did not fall above curve 1 or below curve 2.

 

    Discussion
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
The results presented above show that AI is present in the great majority of very small adenomas. This imbalance was seen not only in chromosome 5q, home of the APC gene, but also in several other chromosomes. Our interpretation of these data is that CIN occurs early during colorectal neoplasia, long before the advent of malignancy. These results support the idea that such instability is essential for neoplasia (20) .

Although the above represents our preferred interpretation, several alternative interpretations should be pointed out:

(a) We have studied tumors at a single time point. Although our data are consistent with the existence of a true instability (which can only be measured through a time course, not through a single determination), other scenarios are conceivable. For example, it is possible that one abnormal division occurred during the tumorigenic process, leading to AI at multiple loci, and that there was no persistent chromosomal instability in these lesions. We cannot infer from our static observations any quantitative estimate of the rate of chromosomal loss and can only state that the AI we observed is consistent with a chromosomal instability such as that formally demonstrated in CRC cell lines in vitro (21) .

(b) A second proviso concerns the term "early." The selected adenomas were the smallest tumors generally noted during pathological examination of surgically excised tissues and were also the smallest from which we could reproducibly obtain a sufficient number of alleles for analysis with several probes. However, these ~2-mm adenomas contain ~1 x 106 neoplastic cells, and the term "early" is a relative one. On the basis of clinical studies, it would likely take 10–30 years for these tiny adenomas to progress to malignancy (22) , and it therefore is legitimate to label them "early."

How do our results compare with previous molecular studies of AI? Although allelic imbalances of chromosome 5q were expected (15 , 23 , 24) , the other AIs were surprising. For example, loss of heterozygosity of chromosomes 1p, 8p, 15q, and 18q have previously been observed rarely in adenomas, even in large ones (23 , 25, 26, 27, 28) . There are two factors that might reconcile these observations: (a) the digital SNP method we used is more sensitive than previous methods to detect allelic loss. Some of the AIs we observed might have been present in only 50% of the neoplastic cells, for example, and standard techniques would not have detected them. Digital SNP reliably discerns AI but cannot distinguish (for example) whether this AI is attributable to allelic loss in 100% of the neoplastic cells in a specimen composed of 50% nonneoplastic cells versus allelic loss in 60% of the neoplastic cells in a specimen composed of 80% neoplastic cells. We therefore might be observing losses in major subpopulations of neoplastic cells that only become completely clonal at later stages of tumorigenesis. Such progression has been observed previously in colon and other tumors (24 , 29 , 30) . Additionally, our analysis does not distinguish between chromosome gains and chromosome losses as the cause of the AI. Previous studies that concentrated on loss of heterozygosity might not have detected chromosome gains. From a CIN (rather than functional) point of view, chromosome gains and losses are equally important and indicative of instability (3) . It is also noteworthy that the chromosomes we analyzed harbor tumor suppressor genes, and losses of such chromosomes may result in a selective growth advantage. Whether such losses confer a selective advantage, or are simply random, does not affect the data or conclusions of this study.

Previous cytogenetic and flow cytometric studies of colorectal neoplasms are in general consistence with our observations, although there have been very few examinations of colorectal tumors as small as those studied here. There have been several reports of aneuploidy in larger adenomas, with the suggestion that aneuploidy increases with tumor progression (8, 9, 10, 11, 12) . Accordingly, our study showed that AI in adenomas (Fig. 4)Citation is much less common than that in cancers studied previously. Indeed, it is not uncommon to observe AI in over one-third of the total chromosomes in primary tumors (30) , and chromosomes 1p, 8p, and 18q exhibit allelic losses in a much higher proportion of cancers (14 , 23 , 31 , 32) than in small adenomas (Fig. 4)Citation . If CIN began early, one would expect to see increasing degrees of aneuploidy as tumors enlarged, because of repeated rounds of clonal selection.

Our observations and conclusions are also consistent with those made on the early stages of other tumor types. For example, AI has been found in metaplastic lesions associated with gastric carcinoma (33) , in intraepithelial neoplasia of the vulva (34) , in dysplastic esophageal epithelium in Barrett’s esophagus (35) , and in fibrocystic changes of breast (36) . Although the temporal relationship between such lesions and cancer is less well defined than in colorectal tumorigenesis, such studies support the idea that CIN is an early component of human neoplasia in general.

It is interesting to speculate whether CIN precedes the advent of APC gene mutations. Studies in mice, as well as in humans, have shown that APC inactivation occurs very early during the neoplastic process (reviewed in Ref. 37 ). In many cases, this inactivation involves mutation of one allele and loss of the other. Such inactivations could occur in two ways. A mutation in one APC allele could occur first, followed by a loss of the second allele, or vice versa. In either case, the allelic loss event could be precipitated by CIN, although occasional allelic losses also occur in normal cells that are chromosomally stable (38, 39, 40) . As a working hypothesis, we propose that CIN drives the allelic loss of chromosome 5 in some cases and that CIN may already be present in a proportion of the tiny neoplastic lesions containing APC mutations. This hypothesis can only be convincingly refuted or confirmed once the mechanism(s) underlying CIN is identified.


    ACKNOWLEDGMENTS
 
We thank the members in Molecular Genetics laboratory for their critical comments and The Johns Hopkins Oncology Center Cell Imaging Core Facility for help with photography. Under a licensing agreement between the Johns Hopkins University and EXACT Laboratories, Inc., Digital PCR technology was licensed to EXACT, and Drs. Vogelstein and Kinzler are entitled to a share of royalties received by the University from sales of the licensed technology. The terms of these arrangements are being managed by the University in accordance with its conflict of interest policies.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Clayton Fund, the V Foundation, and NIH Grants CA43460, CA 57345, and CA62924. Back

2 To whom requests for reprints should be addressed, at Johns Hopkins Oncology Center, 1650 Orleans Street, Baltimore, MD 21231. E-mail: vogelbe{at}welch.jhu.edu Back

3 The abbreviations used are: CRC, colorectal cancer; MIN, microsatellite instability; CIN, chromosomal instability; SNP, single-nucleotide polymorphism; AI, allelic imbalance; APC, adenomatous polyposis coli; SPRT, sequential probability ratio test. Back

4 Internet address: http://www.genome.wi.mit.edu/SNP/human/index.html. Back

5 Internet address: http://lpg.nci.nih.gov/html-snp/imagemaps.html. Back

4 W. Zhou, G. Galizia, S. Goodman, K. Romans, E. Lieto, K. W. Kinzler, B. Vogelstein, M. Choti, and E. Montgomery, unpublished observations.

Received 10/12/00. Accepted 12/13/00.


    REFERENCES
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 

  1. Kinzler K. W., Vogelstein B. Colorectal tumors. Vogelstein B. Kinzler K. W. eds. . The Genetic Basis of Human Cancer, : 565-587, McGraw-Hill New York 1998.
  2. Loeb L. A. Mutator phenotype may be required for multistage carcinogenesis.. Cancer Res., 51: 3075-3079, 1991.[Free Full Text]
  3. Lengauer C., Kinzler K. W., Vogelstein B. Genetic instabilities in human cancers.. Nature (Lond.), 396: 643-649, 1998.[Medline]
  4. Perucho M. Cancer of the microsatellite mutator phenotype.. Biol. Chem., 377: 675-684, 1996.
  5. Markowitz S. DNA repair defects inactivate tumor suppressor genes and induce hereditary and sporadic colon cancers.. J. Clin. Oncol., 18: 75s-80s, 2000.[Free Full Text]
  6. Cahill D. P., Kinzler K. W., Vogelstein B., Lengauer C. Genetic instability and Darwinian selection in tumours.. Trends Cell Biol., 9: M57-M60, 1999.[Medline]
  7. Huang J., Papadopoulos N., McKinley A. J., Farrington S. M., Curtis L. J., Wyllie A. H., Zheng S., Willson J. K. V., Markowitz S. D., Morin P., Kinzler K. W., Vogelstein B., Dunlop M. G. APC mutations in colorectal tumors with mismatch repair deficiency.. Proc. Natl. Acad. Sci. USA, 93: 9049-9054, 1996.[Abstract/Free Full Text]
  8. Giaretti W., Sciallero S., Bruno S., Geido E., Aste H., Di Vinci A. DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas.. Cytometry, 9: 238-244, 1988.[Medline]
  9. Giaretti W., Rapallo A., Pujic N., Nigro S., Geido E., Risio M., Di Vinci A. K-ras2 mutation spectrum, DNA aneuploidy, and epithelial cell proliferation in colorectal adenomas.. Ann. NY Acad. Sci., 768: 261-263, 1995.[Medline]
  10. Giaretti W. A model of DNA aneuploidization and evolution in colorectal cancer.. Lab. Investig., 71: 904-910, 1994.[Medline]
  11. Rapallo A., Sciutto A., Geido E., Orecchia R., Infusini E., Pujic N., d’Amore E. S., Monaco R., Risio M., Rossini F. P., Giaretti W. K-ras2 activation and genome instability increase proliferation and size of FAP adenomas.. Anal. Cell. Pathol., 19: 39-46, 1999.[Medline]
  12. van den Ingh H. F., Griffioen G., Cornelisse C. J. Flow cytometric detection of aneuploidy in colorectal adenomas.. Cancer Res., 45: 3392-3397, 1985.[Abstract/Free Full Text]
  13. Vogelstein B., Kinzler K. W. Digital PCR.. Proc. Natl. Acad. Sci. USA, 96: 9236-9241, 1999.[Abstract/Free Full Text]
  14. Zhou W., Galizia G., Goodman S. N., Romans K. E., Kinzler K. W., Choti M. A., Montgomery E. A., Vogelstein B. Counting alleles reveals a connection between chromosome 18q loss and vascular invasion.. Nat. Biotechnol., 19: 78-81, 2001.[Medline]
  15. Powell S. M., Zilz N., Beazer-Barclay Y., Bryan T. M., Hamilton S. R., Thibodeau S. N., Vogelstein B., Kinzler K. W. APC mutations occur early during colorectal tumorigenesis.. Nature (Lond.), 359: 235-237, 1992.[Medline]
  16. Tyagi S., Kramer F. R. Molecular beacons: probes that fluoresce upon hybridization.. Nat. Biotechnol., 14: 303-308, 1996.[Medline]
  17. Tyagi S., Bratu D. P., Kramer F. R. Multicolor molecular beacons for allele discrimination.. Nat. Biotechnol., 16: 49-53, 1998.[Medline]
  18. Royall, R. Statistical Evidence: A Likelihood Primer. London: Chapman and Hall, 1997.
  19. Liu J., Zabarovska V. I., Braga E., Alimov A., Klien G., Zabarovsky E. R. Loss of heterozygosity in tumor cells requires re-evaluation: the data are biased by the size-dependent differential sensitivity of allele detection.. FEBS Lett., 462: 121-128, 1999.[Medline]
  20. Duesberg P., Rasnick D. Aneuploidy, the somatic mutation that makes cancer a species of its own.. Cell Motil. Cytoskeleton, 47: 81-107, 2000.[Medline]
  21. Lengauer C., Kinzler K. W., Vogelstein B. Genetic instability in colorectal cancers.. Nature (Lond.), 386: 623-627, 1997.[Medline]
  22. Stryker S. J., Wolff B. G., Culp C. E., Libbe S. D., Ilstrup D. M., MacCarty R. L. Natural history of untreated colonic polyps.. Gastroenterology, 93: 1009-1013, 1987.[Medline]
  23. Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Preisinger A. C., Leppert M., Nakamura Y., White R., Smits A. M., Bos J. L. Genetic alterations during colorectal-tumor development.. N. Engl. J. Med., 319: 525-532, 1988.[Abstract]
  24. Boland C. R., Sato J., Appelman H. D., Bresalier R. S., Feinberg A. P. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression.. Nat. Med., 1: 902-909, 1995.[Medline]
  25. Lamlum H., Papadopoulou A., Ilyas M., Rowan A., Gillet C., Hanby A., Talbot I., Bodmer W., Tomlinson I. APC mutations are sufficient for the growth of early colorectal adenomas.. Proc. Natl. Acad. Sci. USA, 97: 2225-2228, 2000.[Abstract/Free Full Text]
  26. Tomlinson I., Rahman N., Frayling I., Mangion J., Barfoot R., Hamoudi R., Seal S., Northover J., Thomas H. J., Neale K., Hodgson S., Talbot I., Houlston R., Stratton M. R. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14–q22.. Gastroenterology, 116: 789-795, 1999.[Medline]
  27. Lothe R. A., Andersen S. N., Hofstad B., Meling G. I., Peltomaki P., Heim S., Brogger A., Vatn M., Rognum T. O., Borresen A. L. Deletion of 1p loci and microsatellite instability in colorectal polyps.. Genes Chromosomes Cancer, 14: 182-188, 1995.[Medline]
  28. Cunningham C., Dunlop M. G., Bird C. C., Wyllie A. H. Deletion analysis of chromosome 8p in sporadic colorectal adenomas.. Br. J. Cancer, 70: 18-20, 1994.[Medline]
  29. Shibata D., Schaeffer J., Li Z. H., Capella G., Perucho M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.. J. Natl. Cancer Inst., 85: 1058-1063, 1993.[Abstract/Free Full Text]
  30. Sidransky D., Frost P., Von Eschenbach A., Oyasu R., Preisinger A. C., Vogelstein B. Clonal origin bladder cancer.. N. Engl. J. Med., 326: 737-740, 1992.[Abstract]
  31. Vogelstein B., Fearon E. R., Kern S. E., Hamilton S. R., Preisinger A. C., Nakamura Y., White R. Allelotype of colorectal carcinomas.. Science (Washington DC), 244: 207-211, 1989.[Abstract/Free Full Text]
  32. Thiagalingam S. Evaluation of chromosome 18q in colorectal cancers.. Nat. Genet., 13: 343-346, 1996.[Medline]
  33. Kobayashi K., Okamoto T., Takayama S., Akiyama M., Ohno T., Yamada H. Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach.. Eur. J. Cancer, 36: 1113-1119, 2000.
  34. Pinto A. P., Lin M. C., Sheets E. E., Muto M. G., Sun D., Crum C. P. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva.. Gynecol. Oncol., 77: 171-176, 2000.[Medline]
  35. Galipeau P. C., Prevo L. J., Sanchez C. A., Longton G. M., Reid B. J. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett’s) tissue.. J. Natl. Cancer Inst., 91: 2087-2095, 1999.[Abstract/Free Full Text]
  36. Washington C., Dalbegue F., Abreo F., Taubenberger J. K., Lichy J. H. Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.. Am. J. Pathol., 157: 323-329, 2000.[Abstract/Free Full Text]
  37. Kinzler, K. W., and Vogelstein, B. The Genetic Basis of Human Cancer. Toronto: McGraw-Hill, 1998, pp. 565–587.
  38. de Nooij-van Dalen A. G., van Buuren-van Seggelen V. H., Lohman P. H., Giphart-Gassler M. Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro. Genes Chromosomes Cancer, 21: 30-38, 1998.[Medline]
  39. Vrieling H., Wijnhoven S., van Sloun P., Kool H., Giphart-Gassler M., van Zeeland A. Heterozygous Aprt mouse model: detection and study of a broad range of autosomal somatic mutations in vivo.. Environ. Mol. Mutagen., 34: 84-89, 1999.[Medline]
  40. Van Sloun P. P., Wijnhoven S. W., Kool H. J., Slater R., Weeda G., van Zeeland A. A., Lohman P. H., Vrieling H. Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice.. Nucleic Acids Res., 26: 4888-4894, 1998.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Sidelnikov, R. M. Bostick, W. D. Flanders, Q. Long, V. L. Cohen, C. Dash, M. E. Seabrook, and V. Fedirko
MutL-Homolog 1 Expression and Risk of Incident, Sporadic Colorectal Adenoma: Search for Prospective Biomarkers of Risk for Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1599 - 1609.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. D. Siegmund, P. Marjoram, Y.-J. Woo, S. Tavare, and D. Shibata
Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers
PNAS, March 24, 2009; 106(12): 4828 - 4833.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. J. McManus, I. J. Barrett, Y. Nouhi, and P. Hieter
Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing
PNAS, March 3, 2009; 106(9): 3276 - 3281.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Wang, T. D. Allen, R. J. May, S. Lightfoot, C. W. Houchen, and M. M. Huycke
Enterococcus faecalis Induces Aneuploidy and Tetraploidy in Colonic Epithelial Cells through a Bystander Effect
Cancer Res., December 1, 2008; 68(23): 9909 - 9917.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Odoux, H. Fohrer, T. Hoppo, L. Guzik, D. B. Stolz, D. W. Lewis, S. M. Gollin, T. C. Gamblin, D. A. Geller, and E. Lagasse
A Stochastic Model for Cancer Stem Cell Origin in Metastatic Colon Cancer
Cancer Res., September 1, 2008; 68(17): 6932 - 6941.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. P. Degtyareva, L. Chen, P. Mieczkowski, T. D. Petes, and P. W. Doetsch
Chronic Oxidative DNA Damage Due to DNA Repair Defects Causes Chromosomal Instability in Saccharomyces cerevisiae
Mol. Cell. Biol., September 1, 2008; 28(17): 5432 - 5445.
[Abstract] [Full Text] [PDF]


Home page
J R Soc InterfaceHome page
N. L Komarova, A. V Sadovsky, and F. Y.M Wan
Selective pressures for and against genetic instability in cancer: a time-dependent problem
J R Soc Interface, January 6, 2008; 5(18): 105 - 121.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. Capper, B. Britt-Compton, M. Tankimanova, J. Rowson, B. Letsolo, S. Man, M. Haughton, and D. M. Baird
The nature of telomere fusion and a definition of the critical telomere length in human cells
Genes & Dev., October 1, 2007; 21(19): 2495 - 2508.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. M. Caldwell, R. A. Green, and K. B. Kaplan
APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice
J. Cell Biol., September 24, 2007; 178(7): 1109 - 1120.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Perez de Castro, G. de Carcer, and M. Malumbres
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
Carcinogenesis, May 1, 2007; 28(5): 899 - 912.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. W. Y. Yuen, C. D. Warren, O. Chen, T. Kwok, P. Hieter, and F. A. Spencer
Systematic genome instability screens in yeast and their potential relevance to cancer
PNAS, March 6, 2007; 104(10): 3925 - 3930.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D.S. Kim, J.A. Franklyn, V.E. Smith, A.L. Stratford, H.N. Pemberton, A. Warfield, J.C. Watkinson, T. Ishmail, M.J.O. Wakelam, and C.J. McCabe
Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity
Carcinogenesis, March 1, 2007; 28(3): 749 - 759.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. Dikovskaya, D. Schiffmann, I. P. Newton, A. Oakley, K. Kroboth, O. Sansom, T. J. Jamieson, V. Meniel, A. Clarke, and I. S. Nathke
Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis
J. Cell Biol., January 16, 2007; 176(2): 183 - 195.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Alberici, E. de Pater, J. Cardoso, M. Bevelander, L. Molenaar, J. Jonkers, and R. Fodde
Aneuploidy Arises at Early Stages of Apc-Driven Intestinal Tumorigenesis and Pinpoints Conserved Chromosomal Loci of Allelic Imbalance between Mouse and Human
Am. J. Pathol., January 1, 2007; 170(1): 377 - 387.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Mattiuzzo, M. Fiore, R. Ricordy, and F. Degrassi
Aneuploidy-inducing capacity of two widely used pesticides
Carcinogenesis, December 1, 2006; 27(12): 2511 - 2518.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
R. A Gatenby
Commentary: Carcinogenesis as Darwinian evolution? Do the math!
Int. J. Epidemiol., October 1, 2006; 35(5): 1165 - 1167.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. L. Donahue, Q. Lin, S. Cao, and H. E. Ruley
Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability
PNAS, August 1, 2006; 103(31): 11642 - 11646.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Luo, G.-Q. Shen, K. A. Stiffler, Q. K. Wang, T. G. Pretlow, and T. P. Pretlow
Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer
Carcinogenesis, June 1, 2006; 27(6): 1153 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Cardoso, L. Molenaar, R. X. de Menezes, M. van Leerdam, C. Rosenberg, G. Moslein, J. Sampson, H. Morreau, J. M. Boer, and R. Fodde
Chromosomal Instability in MYH- and APC-Mutant Adenomatous Polyps.
Cancer Res., March 1, 2006; 66(5): 2514 - 2519.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Camps, G. Armengol, J. del Rey, J. J. Lozano, H. Vauhkonen, E. Prat, J. Egozcue, L. Sumoy, S. Knuutila, and R. Miro
Genome-wide differences between microsatellite stable and unstable colorectal tumors
Carcinogenesis, March 1, 2006; 27(3): 419 - 428.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Tsafrir, M. Bacolod, Z. Selvanayagam, I. Tsafrir, J. Shia, Z. Zeng, H. Liu, C. Krier, R. F. Stengel, F. Barany, et al.
Relationship of Gene Expression and Chromosomal Abnormalities in Colorectal Cancer
Cancer Res., February 15, 2006; 66(4): 2129 - 2137.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. S. Attene-Ramos, E. D. Wagner, M. J. Plewa, and H. R. Gaskins
Evidence That Hydrogen Sulfide Is a Genotoxic Agent
Mol. Cancer Res., January 1, 2006; 4(1): 9 - 14.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Milyavsky, Y. Tabach, I. Shats, N. Erez, Y. Cohen, X. Tang, M. Kalis, I. Kogan, Y. Buganim, N. Goldfinger, et al.
Transcriptional Programs following Genetic Alterations in p53, INK4A, and H-Ras Genes along Defined Stages of Malignant Transformation
Cancer Res., June 1, 2005; 65(11): 4530 - 4543.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Tomonaga, K. Matsushita, M. Ishibashi, M. Nezu, H. Shimada, T. Ochiai, K. Yoda, and F. Nomura
Centromere Protein H Is Up-regulated in Primary Human Colorectal Cancer and Its Overexpression Induces Aneuploidy
Cancer Res., June 1, 2005; 65(11): 4683 - 4689.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
F. Michor
Chromosomal instability and human cancer
Phil Trans R Soc B, March 29, 2005; 360(1455): 631 - 635.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. V. Rao, Y.-M. Yang, M. V. Swamy, T. Liu, Y. Fang, R. Mahmood, M. Jhanwar-Uniyal, and W. Dai
Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability
PNAS, March 22, 2005; 102(12): 4365 - 4370.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. R. Mehta, K. Nakao, M. B. Zuraek, D. T. Ruan, E. K. Bergsland, A. P. Venook, D. H. Moore, T. A. Tokuyasu, A. N. Jain, R. S. Warren, et al.
Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer
Clin. Cancer Res., March 1, 2005; 11(5): 1791 - 1797.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
P.B. GUPTA, S. MANI, J. YANG, K. HARTWELL, and R.A. WEINBERG
The Evolving Portrait of Cancer Metastasis
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 291 - 297.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
A. Tighe, V. L. Johnson, and S. S. Taylor
Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability
J. Cell Sci., December 15, 2004; 117(26): 6339 - 6353.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. B. Geigl, S. Langer, S. Barwisch, K. Pfleghaar, G. Lederer, and M. R. Speicher
Analysis of Gene Expression Patterns and Chromosomal Changes Associated with Aging
Cancer Res., December 1, 2004; 64(23): 8550 - 8557.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. L. Schneider and M. Kulesz-Martin
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
Carcinogenesis, November 1, 2004; 25(11): 2033 - 2044.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Nakao, K. R. Mehta, J. Fridlyand, D. H. Moore, A. N. Jain, A. Lafuente, J. W. Wiencke, J. P. Terdiman, and F. M. Waldman
High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization
Carcinogenesis, August 1, 2004; 25(8): 1345 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Nowak, F. Michor, N. L. Komarova, and Y. Iwasa
Evolutionary dynamics of tumor suppressor gene inactivation
PNAS, July 20, 2004; 101(29): 10635 - 10638.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. A. Woo and R. Y.C. Poon
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation
Genes & Dev., June 1, 2004; 18(11): 1317 - 1330.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. Dikovskaya, I. P. Newton, and I. S. Nathke
The Adenomatous Polyposis Coli Protein Is Required for the Formation of Robust Spindles Formed in CSF Xenopus Extracts
Mol. Biol. Cell, June 1, 2004; 15(6): 2978 - 2991.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. K. Meeker, J. L. Hicks, C. A. Iacobuzio-Donahue, E. A. Montgomery, W. H. Westra, T. Y. Chan, B. M. Ronnett, and A. M. De Marzo
Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
Clin. Cancer Res., May 15, 2004; 10(10): 3317 - 3326.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. H. Carter, L. E. Douglass, J. A. Deddens, B. M. Colligan, T. R. Bhatt, J. O. Pemberton, S. Konicek, J. Hom, M. Marshall, and J. R. Graff
Pak-1 Expression Increases with Progression of Colorectal Carcinomas to Metastasis
Clin. Cancer Res., May 15, 2004; 10(10): 3448 - 3456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Calabrese, S. Tavare, and D. Shibata
Pretumor Progression: Clonal Evolution of Human Stem Cell Populations
Am. J. Pathol., April 1, 2004; 164(4): 1337 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-M. Jeng, S.-Y. Peng, C.-Y. Lin, and H.-C. Hsu
Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma
Clin. Cancer Res., March 15, 2004; 10(6): 2065 - 2071.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Traverso, C. Bettegowda, J. Kraus, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer
Hyper-Recombination and Genetic Instability in BLM-Deficient Epithelial Cells
Cancer Res., December 15, 2003; 63(24): 8578 - 8581.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. A. Green and K. B. Kaplan
Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC
J. Cell Biol., December 8, 2003; 163(5): 949 - 961.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R.-A. Risques, V. Moreno, M. Ribas, E. Marcuello, G. Capella, and M. A. Peinado
Genetic Pathways and Genome-Wide Determinants of Clinical Outcome in Colorectal Cancer
Cancer Res., November 1, 2003; 63(21): 7206 - 7214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Luo, B. Li, and T. P. Pretlow
DNA Alterations in Human Aberrant Crypt Foci and Colon Cancers by Random Primed Polymerase Chain Reaction
Cancer Res., October 1, 2003; 63(19): 6166 - 6169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Gatenby and T. L. Vincent
An Evolutionary Model Of Carcinogenesis
Cancer Res., October 1, 2003; 63(19): 6212 - 6220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. A. French, E. K. Alexander, E. S. Cibas, V. Nose, J. Laguette, W. Faquin, J. Garber, F. Moore Jr, J. A. Fletcher, P. R. Larsen, et al.
Genetic and Biological Subgroups of Low-Stage Follicular Thyroid Cancer
Am. J. Pathol., April 1, 2003; 162(4): 1053 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. M. Sieber, K. Heinimann, P. Gorman, H. Lamlum, M. Crabtree, C. A. Simpson, D. Davies, K. Neale, S. V. Hodgson, R. R. Roylance, et al.
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC
PNAS, December 24, 2002; 99(26): 16910 - 16915.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Nowak, N. L. Komarova, A. Sengupta, P. V. Jallepalli, I.-M. Shih, B. Vogelstein, and C. Lengauer
The role of chromosomal instability in tumor initiation
PNAS, December 10, 2002; 99(25): 16226 - 16231.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H.-W. Chang, S. M. Lee, S. N. Goodman, G. Singer, S. K. R. Cho, L. J. Sokoll, F. J. Montz, R. Roden, Z. Zhang, D. W. Chan, et al.
Assessment of Plasma DNA Levels, Allelic Imbalance, and CA 125 as Diagnostic Tests for Cancer
J Natl Cancer Inst, November 20, 2002; 94(22): 1697 - 1703.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. K. Meeker, J. L. Hicks, E. A. Platz, G. E. March, C. J. Bennett, M. J. Delannoy, and A. M. De Marzo
Telomere Shortening Is an Early Somatic DNA Alteration in Human Prostate Tumorigenesis
Cancer Res., November 15, 2002; 62(22): 6405 - 6409.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. G. Luebeck and S. H. Moolgavkar
Multistage carcinogenesis and the incidence of colorectal cancer
PNAS, November 12, 2002; 99(23): 15095 - 15100.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Rubin and G. R. Anderson
Correspondence re: G. Anderson et al., Intrachromosomal Genomic Instability in Human Sporadic Colorectal Cancer Measured by Genome-Wide Allelotyping and Inter-(Simple Sequence Repeat) PCR. Cancer Res., 61: 8274-8283, 2001.
Cancer Res., November 1, 2002; 62(21): 6350 - 6351.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. T. van Heek, A. K. Meeker, S. E. Kern, C. J. Yeo, K. D. Lillemoe, J. L. Cameron, G. J. A. Offerhaus, J. L. Hicks, R. E. Wilentz, M. G. Goggins, et al.
Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia
Am. J. Pathol., November 1, 2002; 161(5): 1541 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H.-W. Chang, C.-Y. Yen, S.-Y. Liu, G. Singer, and I.-M. Shih
Genotype Analysis Using Human Hair Shaft
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 925 - 929.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. J. Oldt III, R. J. Kurman, and I.-M. Shih
Molecular Genetic Analysis of Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors Confirms Their Trophoblastic Origin
Am. J. Pathol., September 1, 2002; 161(3): 1033 - 1037.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. W. Kirk, M. Feinsod, R. Favis, R. M. Kliman, and F. Barany
Single nucleotide polymorphism seeking long term association with complex disease
Nucleic Acids Res., August 1, 2002; 30(15): 3295 - 3311.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H.-W. Chang, S. Z. Ali, S. K. R. Cho, R. J. Kurman, and I.-M. Shih
Detection of Allelic Imbalance in Ascitic Supernatant by Digital Single Nucleotide Polymorphism Analysis
Clin. Cancer Res., August 1, 2002; 8(8): 2580 - 2585.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Haigis, J. G. Caya, M. Reichelderfer, and W. F. Dove
Intestinal adenomas can develop with a stable karyotype and stable microsatellites
PNAS, June 25, 2002; 99(13): 8927 - 8931.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Fabarius, A. Willer, G. Yerganian, R. Hehlmann, and P. Duesberg
Specific aneusomies in Chinese hamster cells at different stages of neoplastic transformation, initiated by nitrosomethylurea
PNAS, May 14, 2002; 99(10): 6778 - 6783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Singer, R. J. Kurman, H.-W. Chang, S. K.R. Cho, and I.-M. Shih
Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma
Am. J. Pathol., April 1, 2002; 160(4): 1223 - 1228.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. M. Huycke, V. Abrams, and D. R. Moore
Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA
Carcinogenesis, March 1, 2002; 23(3): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-Q. Ding, S. M. Kuntz, and L. J. Miller
A Misspliced Form of the Cholecystokinin-B/Gastrin Receptor in Pancreatic Carcinoma: Role of Reduced Cellular U2AF35 and a Suboptimal 3'-Splicing Site Leading to Retention of the Fourth Intron
Cancer Res., February 1, 2002; 62(3): 947 - 952.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Bunz, C. Fauth, M. R. Speicher, A. Dutriaux, J. M. Sedivy, K. W. Kinzler, B. Vogelstein, and C. Lengauer
Targeted Inactivation of p53 in Human Cells Does Not Result in Aneuploidy
Cancer Res., February 1, 2002; 62(4): 1129 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Lengauer
How do tumors make ends meet?
PNAS, October 23, 2001; 98(22): 12331 - 12333.
[Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
M. Chicurel
Dangerous Liaisons
Sci. Aging Knowl. Environ., October 3, 2001; 2001(1): oa3 - 3.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I.-M. Shih, T.-L. Wang, G. Traverso, K. Romans, S. R. Hamilton, S. Ben-Sasson, K. W. Kinzler, and B. Vogelstein
Top-down morphogenesis of colorectal tumors
PNAS, February 15, 2001; (2001) 51629398.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
I.-M. Shih, T.-L. Wang, G. Traverso, K. Romans, S. R. Hamilton, S. Ben-Sasson, K. W. Kinzler, and B. Vogelstein
Top-down morphogenesis of colorectal tumors
PNAS, February 27, 2001; 98(5): 2640 - 2645.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, I.-M.
Right arrow Articles by Vogelstein, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shih, I.-M.
Right arrow Articles by Vogelstein, B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online